Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 0404-9826

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 0404-9826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Formula2.jpg (Formula2)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This text provides information about Bupivacaine Hydrochloride Injection, USP which is available in three different concentrations (0.25%, 0.5%, and 0.75%). Each concentration has different amounts of Bupivacaine Hydrochloride and Sodium Chloride per mL. This product does not contain epinephrine.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This is a table displaying the contents of Bupivacaine and Epinephrine Injection, USP, including the amounts of Bupivacaine Sodium Hydrochloride Chloride and Epinephrine per milliliter. It lists three different concentrations with varying amounts of Bupivacaine Sodium Hydrochloride Chloride and a consistent amount of Epinephrine.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
This is a list of drugs that are associated with methemoglobinemia. Methemoglobinemia is a condition where the blood is not able to carry oxygen properly due to the presence of methemoglobin. The drugs that are listed here fall into several categories including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Some of the specific examples of drugs listed include nitric oxide, nitroglycerin, chloroquine, and phenobarbital. Methemoglobinemia is a serious medical condition and can occur as a result of exposure to certain drugs or chemicals.*
FDA Label Image

Image4,jpg (Image4)

Image4,jpg (Image4)
This appears to be a chart or table listing different types of anesthesia and the recommended dosages for each. It includes information on local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, and test dose with Ej 10-15 mic. The chart lists the concentration of each type of dose and the recommended range of mL and mg for each.*
FDA Label Image

Image6.jpg (Image6)

Image6.jpg (Image6)
This is a list of different products with their respective NDC codes and presentations, all containing a concentration of 2.5mg/mi. Some come in single-dose Teartop vials while others come in multiple-dose Fliptop vials. The pH for all of them is 331055. Some are sold in cartons, trays, or cases, and they differ in the content of vials per package.*
FDA Label Image

Image7.jpg (Image7)

Image7.jpg (Image7)
This is a list of different unit of sales and concentrations for various medications, which includes single-dose teartop vials, cartons, trays, and multiple-dose fliptop vials. They are available in different sizes and concentrations measured in milligrams per milliliter, with NDC codes assigned to each of them.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is a product information sheet for a 0.25% Bupivacaine HCL injection for infiltration and nerve block use in sterile, non-pyrogenic, 2.6 mg/mL injection USP solution with 125mg/0.0mL. The product comes in a 50 Rai multiple-dose fliptop vial and is not meant for use in caudal, epidural or spinal anesthesia. The product should be stored in a cool, dry place between 15ºC and 30°C, and kept out of reach of children. A GTIN(01)X0000000000000C is listed, as well as an ITEM# 12650448. There is additional contact information for inquiries regarding the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.